Denosumab is a RANK Ligand inhibitor. It significantly increases bone mineral density (BMD) in the total hip, lumbar spine, distal 1/3 radius and total body compared to placebo.
A website dedicated to human pathology
| PubMed | eMedicine | OMIM | Google | Google images | Yahoo images | YouTube |
Denosumab is a RANK Ligand inhibitor. It significantly increases bone mineral density (BMD) in the total hip, lumbar spine, distal 1/3 radius and total body compared to placebo.